Company Overview

Update
Founded:
2005
Founders:
John E. Edwards, Brad Spellberg
Headquarters:
Grand Forks, ND
Funding:
$34.60M
Categories:
Biotechnology

NovaDigm Therapeutics develops vaccines that protect patients from contracting fungal and bacterial infections.

Description

Update

NovaDigm Therapeutics, Inc. develops vaccines to protect patients from fungal and bacterial infections. Its products include NDV-3, a vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by fungal and bacterial pathogens; and Als3, an antigen vaccine, which provides protection against systemic and mucosal candidal infections. NovaDigm Therapeutics, Inc. was founded in 2005 and is based in Grand Forks, North Dakota.

Current Team (3)

Update

Board Members and Advisors (1)

Update

Funding Rounds (2) - $34.60M

Update

Investors (2)

Update
  • 0a3acad2d1a668f5769bee7f82e0eb3a

    Domain Associates

    Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on..
  • 5c88874bab246f05ba9ce93503ddf1d4

    RusnanoMedInvest

    RusnanoMedInvest invests in pharmaceuticals and medical developmental businesses based in the U.S...

Offices/Locations (1)

Update
  • Office

    4201 James Ray Drive REAC 1 Building

    Suite 2200

    Grand Forks, ND 58202

    USA